Corley, Michael J.
Pang, Alina P. S.
Kitch, Douglas W.
Kantor, Amy
Sattler, Fred
Belaunzaran-Zamudio, Pablo F.
Brown, Todd T.
Landay, Alan
Lake, Jordan E.
Erlandson, Kristine M.
Funding for this research was provided by:
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
National Institutes of Health (UM1 AI068634, UM1 AI068636, UM1 AI106701, K24 AI120834, K24 AG082527)
James B. Pendleton Charitable Trust
Article History
Received: 23 September 2025
Accepted: 31 March 2026
First Online: 21 April 2026
Competing interests
: M.J.C. serves as a scientific advisor for TruDiagnostic. A.P.S.P. declares no disclosures. K.M.E. has received research funding from the NIH/NIA in support of the present manuscript; outside of the current work, she has received research funding from Gilead Sciences and has consulted for Gilead Sciences, Merck, and ViiV Pharmaceuticals, all paid to her institution. T.T.B. has served as a consultant to Merck, ViiV Healthcare, EMD Serono, and Janssen. P.F.B.-Z. is the Division of AIDS medical officer for the study; however, his views are personal and do not represent the NIH/NIAID’s views.